CIK 0001636282 · Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464312787
- Phone
- 6176515940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −600 | $89.14 | $53K | 551,940 |
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −2,683 | $90.10 | $242K | 549,257 |
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −2,638 | $91.49 | $241K | 546,619 |
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −3,989 | $92.31 | $368K | 542,630 |
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −4,990 | $93.37 | $466K | 537,640 |
| 2026-10-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −100 | $93.91 | $9K | 537,540 |
| 2026-09-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −2,500 | $86.36 | $216K | 565,040 |
| 2026-09-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −8,400 | $87.15 | $732K | 556,640 |
| 2026-09-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −3,700 | $88.06 | $326K | 552,940 |
| 2026-09-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −400 | $89.07 | $36K | 552,540 |
| 2026-08-03 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −800 | $93.97 | $75K | 581,740 |
| 2026-08-03 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −7,157 | $95.10 | $681K | 574,583 |
| 2026-08-03 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −5,635 | $95.93 | $541K | 568,948 |
| 2026-08-03 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −1,392 | $96.82 | $135K | 567,556 |
| 2026-08-03 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −16 | $97.46 | $2K | 567,540 |
| 2026-07-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −10,176 | $87.44 | $890K | 587,364 |
| 2026-07-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −4,234 | $88.12 | $373K | 583,130 |
| 2026-07-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −590 | $88.91 | $52K | 582,540 |
| 2026-06-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −3,557 | $69.40 | $247K | 608,983 |
| 2026-06-01 | Turtle Cameron Chief Executive Officer | Sale 10b5-1 | −8,149 | $70.50 | $575K | 600,834 |
Page 1 of 3 · 47 trades